<DOC>
	<DOCNO>NCT00993759</DOCNO>
	<brief_summary>The purpose study determine 3804-250A prevent common cold cause rhinovirus apply hand . The study also evaluate whether 3804-250A prevent rhinovirus infection common cold illness . The study also evaluate safety 3804-250A .</brief_summary>
	<brief_title>Efficacy Study A Lotion Prevent Common Colds</brief_title>
	<detailed_description>Rhinovirus infection frequent cause 80 % cold illness fall rhinovirus season . While viral upper respiratory tract infection generally mild self-limiting , associate enormous economic burden , lose productivity expenditures treatment . Rhinovirus infection frequently associate medical complication substantial morbidity acute otitis medium exacerbation asthma . Marketed treatment option common cold consist primarily symptomatic cold remedy effect specific cold symptom . 3804-250A topical treatment investigation prevention rhinovirus-associated cold interruption person-to-person transmission . The study randomize trial conduct 9-week period fall rhinovirus epidemic season . Healthy , normal subject randomly assign one two treatment group : 1 . AV Lotion 2 . No Treatment control . Subjects 3804-250A group use treatment define schedule . The No Treatment control group maintain regular hand wash routine . All subject record presence cold illness symptom daily . Subjects return study site weekly study specimen collection rhinovirus PCR , evaluation irritation , review clarification study diary entry , review assessment compliance , collection adverse event replenishment study supply . In addition , first five week study , subject AV Lotion group attend second weekly compliance visit diary test product consumption assess compliance collection adverse event . Photographs hand take subject withdraw skin irritation . The incidence cold illness , rhinovirus-associated cold illness rhinovirus infection compare treatment group .</detailed_description>
	<mesh_term>Common Cold</mesh_term>
	<criteria>Read sign copy approve Consent Form ; 1840 year age ; If woman child bear potential ( WOCBP ) must negative urine pregnancy test use effective method birth control , limited , birth control pill , contraceptive foam , diaphragm , IUD , vasectomize partner , abstinence , condom ; Capable compliance require study sick visit ( i.e. , plan travel commitment ) ; Willing follow study restriction ; Generally good health base medical history interview . Current participation study ; Participation investigational drug study within 30 day enrollment ; Participation within 30 day enrollment study hand test site ; Pregnancy ( determine urine pregnancy test ) , lactation planning pregnancy course study ; Daily smoker ; Current significant history sinusitis ; Skin condition hand wrist would interfere evaluation , scar , tattoo , uneven skin tone , condition ; Allergy soap , detergent , preservative , citric acid , malic acid ethanol ; Immunological disorder ( i.e. , AIDS , HIV , systemic lupus erythematosis , rheumatoid arthritis ) ; Current use use within 7 day prior randomization antibacterial medication treatment respiratory infection ; Current use use within 7 day enrollment topical drug ( e.g . hydrocortisone corticosteroid ) treat skin condition hand wrist , except localize treatment minor cut scrape ; Occupational requirement unusually frequent hand wash ( i.e . health care worker , food service worker ) ; Currently suffer respiratory allergy history seasonal respiratory allergy normally active study period ; History dermatologic disease hand , wrist arm ; History 3rd degree burn and/or skin graft hand wrist ; History significant frequent skin soft tissue infection ; Use androgens , immunomodulators ( growth factor , systemic corticosteroid , immune globulin , interleukin , interferon ) immunosuppressive medication within 30 day prior study entry . Erythema score 1.0 and/or dryness score hand enrollment great Grade 0 ; Subject experience cold ; The subject TM &amp; R006208TXC discontinue irritation , experienced test product relate skin reaction withdraw study exclude perprotocol analysis noncompliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>common cold</keyword>
	<keyword>rhinovirus</keyword>
	<keyword>prevention</keyword>
</DOC>